IL-1RAP as a promising therapeutic target in several hematological and solid cancers.

A new review article, co-authored by Drs Jame Frenay and Pierre-Simon Bellaye (Supervisor: Dr Alexandre Dias), has just been published by IMATHERa (CGFL – Dr B. Collin, ICMUB UMR CNRS 6302). This literature review highlights the fact that IL-1RAP, a receptor involved in the inflammatory response, is now considered as a promising therapeutic target in several hematological and solid cancers: see publication.